Physician profile
Soma Kumar
NPI 1356502520
$404.36
in general payments reported to CMS, 2019-2025
8 companies · $64.09 in 2025
The $64.09 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $45.71 · 2021: $92.18 · 2022: $1.02 · 2024: $22.85 · 2025: $64.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $211.60 | 2019-2021 | |
| Travere Therapeutics, INC. | $48.03 | 2019-2022 | |
| Kaleo, INC. | $41.84 | 2019-2020 | |
| Qol Medical, LLC | $31.81 | 2025 | Sucraid |
| Mirum Pharmaceuticals, INC. | $22.85 | 2024 | Livmarli |
| Takeda Pharmaceuticals U.S.A., INC. | $18.68 | 2025 | Eohilia |
| Terumo Medical Corporation | $15.95 | 2020 | |
| Celltrion USA INC. | $13.60 | 2025 | Vegzelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soma Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.